ArticlePediatric nephrology (Berlin, Germany)2026
One-year creatinine predicts long-term graft survival in pediatric kidney transplant recipients.
Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn pediatric kidney transplant, recipients' long-term graft survival remains variable necessitating methods to predict the timing of graft failure. Studies in adults have identified post-transplant serum creatinine (sCr) as a biomarker for graft survival. Our goal was to investigate the predictive value of 1-year sCr levels on long-term graft survival in pediatric kidney recipients.
methodsWe performed a retrospective cohort study of Organ Procurement and Transplantation Network data. We identified 8733 pediatric kidney transplant recipients between 2008 and 2021 with reported 1-year sCr levels. Patients were grouped by sCr level: ≤ 1.0, 1.0-1.5, 1.5-2.0, and ≥ 2.0 mg/dL. We analyzed long-term graft survival with a Kaplan-Meier curve and a multivariable Cox proportional hazards model. We developed a predictive score derived from a sCr-based model and an estimated glomerular filtration rate (eGFR)-based model and compared them using DeLong's test.
resultsMean 1-year sCr was 0.88 mg/dL, and higher 1-year sCr predicted long-term graft failure (sCr 1.0-1.5 adjusted hazard ratio (aHR) 1.73, sCr 1.5-2.0 aHR 2.64, sCr ≥ 2.0 aHR 6.92, p < 0.001 for all). The mean 1-year eGFR was 71.66 mL/min/1.73 m
conclusionsUtilizing 1-year sCr may allow for early identification of patients at risk of graft failure for careful surveillance and prognostication for patients' expectations.
Indexed as
Identifiers
41275057What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.